SCHEMBL30967664

SCHEMBL30967664

[2H]C1([2H])NC(=O)c2cc3c(OC([2H])([2H])C(F)(F)F)nccc3n2C1([2H])[2H]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30967474 0.90 SCN9A (0.32) —
SCHEMBL30967468 0.79 — —
SCHEMBL30967466 0.74 HRH3 (0.39) —
SCHEMBL30967631 0.69 SCN9A (0.34) —
Hydrochloric Acid SCHEMBL30967494 0.68 SCN9A (0.33) —
SCHEMBL30967529 0.67 HRH3 (0.32) —
SCHEMBL30967533 0.65 HRH3 (0.34) —
SCHEMBL30967583 0.65 HRH3 (0.32) —
SCHEMBL30967486 0.65 HRH3 (0.32) —
SCHEMBL30967485 0.62 SCN9A (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615838-A1 SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS Merck Patent GmbH (DE) 2025-09-17 — — EP disclosed
WO-2024099898-A1 SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS MERCK PATENT GMBH (DE) 2024-05-16 — — WO disclosed
Send feedback